公开(公告)号：US20230181705A1

公开(公告)日：2023-06-15

申请号：US17999335

申请日：2021-05-17

Applicant: NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY

Inventor： Guangjun NIE ,  Ruifang ZHAO ,  Long CHEN ,  Hao QIN ,  Yuliang ZHAO

IPC: A61K39/00 ,  A61K39/39 ,  A61K9/50 ,  A61K9/48 ,  A61P35/00

CPC classification number: A61K39/0011 ,  A61K39/39 ,  A61K9/5068 ,  A61K9/4866 ,  A61P35/00 ,  A61K2039/55594 ,  A61K2039/55516 ,  A61K2039/6093

Abstract: A tumor vaccine, a preparation method therefor, and use of the tumor vaccine thereof. A pharmaceutical combination with a first membrane component having a membrane derived from the inner membrane of bacteria, the pharmaceutical combination further includes components derived from other organisms than the bacteria. A method for enhancing an uptake of a target antigen by an immune cell, activating an immune cell, enhancing an innate immunity and/or a specific immune response and/or preventing and/or treating a tumor. A tumor vaccine for preventing postoperative recurrence of cancer.